EFAVIRENZ for Depression: Side Effects & Safety Data
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
There are 12 adverse event reports in the FDA FAERS database where EFAVIRENZ was used for Depression.
Most Reported Side Effects for EFAVIRENZ
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Virologic failure | 916 | 11.6% | 20 | 30 |
| Foetal exposure during pregnancy | 701 | 8.9% | 137 | 83 |
| Drug resistance | 654 | 8.3% | 15 | 40 |
| Drug interaction | 645 | 8.2% | 146 | 133 |
| Viral mutation identified | 641 | 8.1% | 5 | 10 |
| Depression | 602 | 7.6% | 141 | 149 |
| Pathogen resistance | 567 | 7.2% | 0 | 31 |
| Maternal exposure during pregnancy | 478 | 6.1% | 31 | 70 |
| Treatment failure | 390 | 4.9% | 38 | 17 |
| Immune reconstitution inflammatory syndrome | 301 | 3.8% | 47 | 148 |
| Death | 295 | 3.7% | 295 | 41 |
| Exposure during pregnancy | 251 | 3.2% | 26 | 39 |
| Treatment noncompliance | 222 | 2.8% | 13 | 47 |
| Abortion spontaneous | 221 | 2.8% | 39 | 44 |
| Lipodystrophy acquired | 203 | 2.6% | 1 | 19 |
Other Indications for EFAVIRENZ
Hiv infection (5,261)
Product used for unknown indication (1,314)
Antiretroviral therapy (580)
Acquired immunodeficiency syndrome (191)
Hiv test positive (64)
Hepatitis c (45)
Perinatal hiv infection (41)
Prophylaxis against hiv infection (40)
Hiv infection who clinical stage iii (35)
Maternal exposure timing unspecified (33)
Other Drugs Used for Depression
SERTRALINE (14,497)
VENLAFAXINE (11,868)
DULOXETINE (11,681)
ESKETAMINE (10,058)
ESCITALOPRAM OXALATE (7,373)
FLUOXETINE (7,035)
BUPROPION (6,165)
MIRTAZAPINE (6,021)
CITALOPRAM HYDROBROMIDE (5,450)
PAROXETINE (5,386)